Skip to content
GLP-1 Scorecard
Menu
Site position #298

Claya

Published by GLP-1 ScorecardUpdated

Claya is a direct-to-consumer telehealth platform offering compounded semaglutide and tirzepatide in both injectable and oral-tablet forms — a wider format range than most competitors.

Visit ClayaWe may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Semaglutide
$299/mo (compounded)
Tirzepatide
$299/mo (compounded)
Coverage
Coverage not published
Brand-name
Not confirmed

Weigh Claya against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. If you are considering a compounded option, read about whether compounded semaglutide is legit and safe.

Factor breakdown

These are recorded editorial marks, not a measure of clinical outcomes. Current prices and policies may differ from those used in the marks. See the methodology.

Cost value42/100
Dose & formulation75/100
Clinical oversight82/100
Labs & monitoring53/100
Fulfillment67/100
Contract terms61/100

Strengths

  • Two named licensed clinicians (Habashy, NMD MS and Barber, MD PhD) — rare transparency for compounded GLP-1
  • Two named pharmacy partners with full addresses (RedRock, UT and Healthware, KY)
  • Both injectable and oral-tablet forms offered for semaglutide and tirzepatide
  • Weight-loss money-back guarantee published on the homepage
  • Free expedited shipping included in the monthly price

What to consider

  • States-served list not disclosed — you must check at checkout
  • LegitScript certification status not displayed
  • Corporate legal entity not disclosed on the site or privacy policy
  • Oral compounded tablets have weaker efficacy data than injectable semaglutide
  • Intro pricing is higher at refill ($299), erasing the first-month advantage

Bottom line — Grade C

Best for: Shoppers who want compounded GLP-1 in injectable and oral-tablet forms with named clinicians.

Site position #298 of 541. Commercial relationships affect placement, not the score. See our featured provider, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest Claya — the realistic shortlist.

The 19 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect Claya's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on Claya's site. Not medical advice; see our disclosure.

← Back to the scorecard